Trials / Sponsors / Poniard Pharmaceuticals

Poniard Pharmaceuticals

Industry · 9 registered clinical trials.

Status	Trial	Phase	Started
Unknown	Cardiac Safety Assessment Study of Picoplatin in Solid Tumors Solid Tumors	Phase 1	2008-06-01
Unknown	Study of Picoplatin Efficacy After Relapse Small Cell Lung Cancer	Phase 3	2007-04-01
Completed	A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors Bladder Cancer, Breast Cancer, Colorectal Cancer	Phase 1	2007-04-01
Unknown	A Study of Picoplatin and Docetaxel in Subjects With Prostate Cancer Hormone Refractory Prostate Cancer	Phase 1 / Phase 2	2006-06-01
Unknown	A Study of Picoplatin in Colorectal Cancer Colorectal Cancer	Phase 1 / Phase 2	2006-04-01
Completed	Picoplatin as Second-Line Therapy for Patients With Small Cell Lung Cancer Small Cell Lung Cancer	Phase 2	2005-06-01
Terminated	Study Comparing STR (Skeletal Targeted Radiotherapy) Plus Melphalan to Melphalan Alone, With Stem Cell Transpl Multiple Myeloma	Phase 3	2004-03-01
Terminated	A Trial of Skeletal Targeted Radiotherapy Using Holmium-166-DOTMP in Patients With Multiple Myeloma Multiple Myeloma	Phase 1 / Phase 2	2002-03-01
Completed	Chemotherapy, Holmium Ho 166 DOTMP, and Peripheral Stem Cell Transplantation in Treating Patients With Multipl Multiple Myeloma and Plasma Cell Neoplasm	Phase 1 / Phase 2	2002-01-01